Companies / Atossa Therapeutics, Inc. / Activity
Activity — Atossa Therapeutics, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | Steinhart Richard I Director | Grant | Common Stock | $0 | +10K | 10,000 0.10% of shares | low |
| Mar 26, 2026 | Daniel Mark James Executive | Grant | Common Stock | $0 | +63K | 63,000 0.63% of shares | low |
| Mar 27, 2026 | Quay Steven C CEO | Grant | Common Stock | $0 | +65K +282.14% | 88,038 0.88% of shares | low |
| Jan 20, 2026 | Quay Steven C CEO | Grant | Common Stock | $0 | +325K +2339.93% | 339,101 3.40% of shares | low |
| Jan 20, 2026 | Quay Steven C CEO | Grant | Common Stock | $0 | +332K +2386.49% | 345,572 3.46% of shares | low |
| Jan 20, 2026 | Quay Steven C CEO | Grant | Stock Options (right to buy) | — | +950K | 950,000 9.52% of shares | low |
| Jan 20, 2026 | Quay Steven C CEO | Grant | Stock Options (right to buy) | — | +950K | 950,000 9.52% of shares | low |